Comparison of several combinations maintenance and reliever therapy for asthma patients
Background: If asthma patients fail to achieve symptom control using a medium dose of inhaled corticosteroid (ICS) alone, addition of a long-acting β2 agonist (LABA) is the preferred treatment. Currently, there are several combinations of ICS/LABA that are available. Objective: Compare the effects...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Colegio Mexicano de Inmunología Clínica y Alergia, A.C.
2018-06-01
|
| Colección: | Revista Alergia México |
| Materias: | |
| Acceso en línea: | http://revistaalergia.mx/ojs/index.php/ram/article/view/423 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|